Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris

13 Dec 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Fungal Infections and Studies
Share to Parasitic Diseases Research and Treatment

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 34915074
DOI: 10.1016/j.cmi.2021.11.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida aurisPMID 34915074Read ↗

<i>In vivo</i> emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in <i>Candida auris</i>Semantic proximity Read ↗

Microevolution of clade II isolates of <i>Candida auris</i> highlights multifaceted intra-clade heterogeneity in acquiring resistance towards amphotericin BSemantic proximity Read ↗

Deciphering the multidrug resistance paradigm in Candida auris.Semantic proximity Read ↗

<i>In vivo</i> evolution of <i>Candida auris</i> multi-drug resistance in a patient receiving antifungal treatmentSemantic proximity Read ↗

Insight into the Mechanisms and Clinical Relevance of Antifungal HeteroresistanceSemantic proximity Read ↗

Candida auris Pan-Drug-Resistant to Four Classes of Antifungal AgentsSemantic proximity Read ↗

In Vivo Evolution of Candida auris Multidrug Resistance in a Patient Receiving Antifungal Treatment.Semantic proximity Read ↗

Multi‐Omics Analysis of Experimentally Evolved Candida auris Isolates Reveals Modulation of Sterols, Sphingolipids, and Oxidative Stress in Acquired Amphotericin B ResistanceSemantic proximity Read ↗

Insight into the Mechanisms and Clinical Relevance of Antifungal HeteroresistanceSemantic proximity Read ↗

Update on antifungal resistance.Semantic proximity Read ↗

Antifungal drug resistance: Deciphering the mechanisms governing multidrug resistance in the fungal pathogen Candida glabrataSemantic proximity Read ↗

Acquired Amphotericin B Resistance Attributed to a Mutated <i>ERG3</i> in <i>Candidozyma auris</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.